The results of this study are of special interest. Aside from the fact that only a prior pilot study, conducted by the same group, had addressed this reliability issue in ET [17] , there were no other published data to aid clinicians and researchers.
Essential tremor (ET) is one of the most common neurological disorders among adults, and it is the most common tremor disorder [1] [2] [3] [4] [5] [6] [7] [8] . As in other neurodegenerative diseases, age of onset in ET is chiefly assessed by the patients' (or occasionally their caregivers') self-report, which may be of little documentary value. Surprisingly, there have been few data that have examined the accuracy of patients' reports of age of onset of ET.
In ET, dating the onset is not a trivial issue. Indeed, age of onset is a variable of considerable importance. First, late-onset ET could have different biochemical and neuropathological underpinnings from earlier-onset ET [9, 10] . Second, as in other neurodegenerative disorders, such as Parkinson's disease [11, 12] , an association between older age of onset and mild cognitive impairment and dementia has been reported in ET (i.e. ET patients with older age of onset are more likely to have mild cognitive impairment and to be demented than are ET patients with younger age of onset, and later onset of ET is a risk factor for incident dementia) [13] [14] [15] . Third, age of onset is crucial when determining the rate of progression in cross-sectional studies [9] .
In this issue of Neuroepidemiology, Louis [16] analyzed the agreement in data on age of onset in 86 patients with ET from a prospective, epidemiological study in New York. Patients with ET were assessed at two time points (baseline and follow-up), and data on age of onset were collected each time by self-report. Despite the observation that agreement between the baseline and follow-up reports was high (p = 0.85, p ! 0.001), and greater agreement was associated with several clinical factors including age, medication use, embarrassment, depressive symptoms, cognitive test score and disease duration, the difference in reported age of onset at the two time points (age of onset baseline -age of onset follow-up ) did range widely (from -47 to 32 years), and in 1/5 of cases was 1 10 years.
